drugset / Trial / NCT01229007
Study of Biostate® in Children With Hemophilia A
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to assess the efficacy and safety of a Von Willebrand Factor/Factor VIII (VWF/FVIII), Biostate, and to investigate the pharmacokinetics of Biostate in children with haemophilia A.
Timeline
- Start
- 2010-08
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Biostate | Protein / enzyme biologic | 50 iu/kg | Intravenous |